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Abstract 
Objective: Substance use disorders and depression in adolescents is a major public 
health issue. The relationship between clinically diagnosed substance use disorder 
and depression has been established. However, this study examined the relationship 
between any drug use and the presence of depressive symptoms in a nationally 
representative sample of high school students in the United States. Methods: Data 
from the 2013 Youth Risk Behavior Survey including 13,583 high school students 
was analyzed. Odds ratios were calculated between substance use, depressive 
symptoms, gender and ethnicity. Binary logistic regression analysis examined the 
association between any drug use and depressive symptoms controlling for gender, 
age, ethnicity, smoking status and alcohol use. Results: Students reporting 
depressive symptoms had a significantly higher risk of drug use (OR=1.454 (1.408-
1.502); p <.001). Males had a higher proportion of drug use (1.060 (1.023-1.099); p 
<.001). Other ethnicities had a higher odds ratio than white students for using any 
drugs (1.176 (1.340-1.219); p <.001). Females had a higher odds ratio for reporting 
depressive symptoms (OR= 1.493 (1.444-1.543); p <.001). Students with depressive 
symptoms had higher rates of drug use, χ2= 132.12, p <.001, b=-0.619, S.E.=0.054, 
Wald=131.569, p <.001. Conclusions: This study established that there is a strong 
association between substance use and depressive symptoms among adolescents. 
The relationship between substance use and depressive symptoms outside of a 
clinical diagnosis demonstrates the need to screen students and intervene early to 
prevent adolescent symptoms from becoming lifelong battles. 
 1 
Introduction 
 
 Mental health disorders are both prevalent and pervasive in society. Kessler et 
al. found that 26.2% of the adult population fits the diagnostic criteria for one of the 
many diagnosable mental disorders (Kessler et al, 2005). This high prevalence rate, 
over a quarter of the population affected, makes mental disorders an important public 
health issue. There are a wide variety of mental disorders, of these, 3.8% are 
reported as a substance use disorder and 6.7% are reported as a major depressive 
disorder (Kessler et al., 2005). There are strict diagnostic criteria used to determine 
the presence of a clinically significant mental disorder, which is diagnosed by a 
physician or specialist. Among these defined mental disorders there are also levels of 
severity: mild, moderate and serious (Kessler et al., 2005). Of diagnosed mental 
disorders, 22.3% presented as serious, 37.3% presented as moderate and 40.4% 
presented as mild (Kessler et al., 2005). Beyond those disorders that are determined 
to be clinically significant and are diagnosed, many people can exhibit symptoms of 
mental disorders without necessarily being diagnosed.  
 Mental disorders often co-occur in the same individual. Co-morbidity of mental 
disorders is extremely common; at least 40% of adults with one lifetime diagnosed 
mental disorder have a history, or current diagnosis, of another mental disorder 
(Kessler et al., 2005; Aseltine et al., 1998). Co-morbidity of mental disorders among 
adolescents is also high (Kessler et al., 2012). This is important in the study of mental 
disorders since very rarely are investigators and clinicians dealing with one specific, 
perfectly isolated mental disorder. One study found that 27.9% of adolescents meet 
criteria for two or more mental disorders and in this group, the average number of 
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disorders was 3.5 (Kessler et al., 2012). Rather, the patients have much more 
complex diagnoses with multiple co-morbidities, all with potentially differing levels of 
severity. This complication of co-morbidity makes identifying those with needs difficult 
and successful treatment plans challenging (Aseltine et al., 1998).  
 A common co-morbidity is that of mood disorders and substance abuse. The 
relationship between depression and substance abuse has been documented in 
adult studies as well as in adolescent studies (Rao, 2006; Weller & Weller, 2000; 
Zullig & Divin, 2012; Martins et al., 2012; Marmorstein et al., 2010; Chinet et al., 
2006; Aseltine et al., 1998; Deykin et al., 1987; Roa et al., 2000). The temporality of 
these two disorders is still unclear, as studies have shown either disorder may 
influence the other disorder (Martins et al., 2012). Kessler et al. (2012) found in a 
retrospective analysis of the NCS-A data that primary mental disorders with age of 
onset within adolescence were predictive of later mental disorders, especially fear 
disorders. People with major depression disorder may self medicate with substances 
to alleviate symptoms and, in turn, substances may induce major depression. In 
whichever order depression or substance abuse occurs in the population, these 
disorders afflict a large percentage of the population and are a current, increasing 
public health issue. Though many studies have been conducted in the adult 
populations, these disorders often begin in adolescence (Kessler et al., 2012).  
 Most of the research available pertaining to substance use disorders and 
depression in adolescents includes clinically diagnosed populations. These are 
adolescents with a clinically significant, diagnosed disorder. One study of African 
American adolescents aged 12 to 18 years, found that 26% were reporting symptoms 
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of depression, but not enough to be clinically diagnosed with depression according to 
DSM-IV standards (Taylor, 2011). Though these adolescents may not be clinically 
diagnosed as having a depressive disorder, they are still exhibiting symptoms of 
depression that could be detrimental to themselves and lead to other negative 
activities such as substance use (Taylor, 2011). In addition, adolescents may use 
different substances, but may not fall under the diagnosable definition of a substance 
use disorder. Adolescents who engage in periodic substance use may still 
experience negative effects and potential hazards of using different substances such 
as increased risk of suicide (Rao et al., 2000; Wong et al., 2013). Large 
epidemiological studies have established the prevalence rates of clinically significant 
and diagnosed disorders, but establishing the prevalence of those who exhibit sub-
threshold symptoms is challenging (Baumeister & Harter, 2007). Often these sub-
threshold symptoms are predictors of a later clinical diagnosis (Baumeister & Harter, 
2007; Taylor, 2011). Using stringent criteria established by diagnostic criteria misses 
a large portion of the adolescent population, who may be suffering from depressive 
symptoms. Even though these adolescent’s symptoms may not rise to the level of a 
clinical diagnosis, they may still have negative effects on that adolescent’s life 
(Deykin et al., 1987). 
 In this study, strict definitions of substance abuse and depression were not 
utilized. In order to measure depression in this study population, one question 
concerning feeling sad for two consecutive weeks over the last twelve months was 
utilized. Though this is not a strict diagnosis of depression, it captures a large number 
of students who may or may not have a diagnosis, but may be showing early signs of 
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depression. As much as 70% of adolescents that show some signs of depression, 
sub-clinically, known as dysthymia, go on to develop a major depressive disorder 
(Weller & Weller, 2000). Though clinical significance may bring a child into a 
pediatrician’s office, it is difficult to determine where the line of significance is exactly. 
It is difficult to determine at what point feeling sad becomes a problem and at what 
point does casual use of illegal and legal substances require intervention. Other 
studies have used various techniques to define depression and depressive 
symptoms. Zullig & Divin (2012) also used generic questions about depressive 
symptoms as a substitute for a clinical diagnosis in order to capture a larger sample 
that may be suffering from any depressive symptoms. 
 Many studies have been done on specific adolescent populations such as 
those in treatment facilities for substance abuse or clinically diagnosed with 
depression with comparatively small sample sizes. This study seeks to examine the 
relationship between drug use and depressive symptoms among a large, nationally 
representative sample of high school students. The differences in substance use 
according to adolescent gender, race and age, as well as differences in the presence 
of depressive symptoms among these groups will be examined. The variables are not 
clinically diagnosed disorders, but representations of those that display clinical 
symptoms of depression or substance abuse.   
Methods 
 This is a cross sectional study based on a secondary data analysis of the 2013 
data set from the Youth Risk Behavior Surveillance System (YRBS). The YRBS was 
developed in 1990 by the Centers for Disease Control and Prevention (CDC) to 
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monitor health risk behaviors that lead to death and/or disability in the United States 
among high school students. Starting in 1991, the CDC has collected data from more 
than 2.6 million high school students. The CDC conducts the YRBS every other year. 
The YRBS is administered to 9th-12th grade students who attend national, state, 
territorial, tribal, local, public and private schools. The YRBS is anonymous and 
voluntary. In the 2013 YRBS, high school students in grades 9 through 12 in all 50 
states and the District of Columbia were included in the sampling. The YRBS uses a 
three-stage cluster sampling design including states and large urban school districts, 
which are sorted by districts and number of students per grade (Brener et al., 2013). 
One or two classes in each grade are randomly chosen from selected schools to 
participate in the YRBS (Brener et al., 2013). For complete details on the sampling 
strategy, see the CDC YRBS methods (Brener et al., 2013). Of the 193 schools 
selected, 148 participated yielding a 77% school response rate. In total, 15,480 
students were sampled and 13,633 of the sampled students submitted 
questionnaires; of those, 13,583 questionnaires were usable after editing, an 88% 
student response rate. The edits conducted by the CDC consisted of reviewing 
surveys for inconsistencies such as an illogical range in height and weight. The 
overall response rate was calculated by multiplying the school response rate by the 
student response rate, which resulted in a total response rate of 68%.  
 The primary outcome measure used for this study was student report of any 
drug use during their lifetime of one or more of the nine substances examined in the 
survey. The nine substances included: marijuana, cocaine, inhalants, heroin, 
methamphetamines, ecstasy, steroids, prescription medications and hallucinogens. 
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Each of these substance variables were recoded into dichotomous variables, with 
yes indicating use one or more times in their lifetime and no indicating that that 
substance was never used. A new summative variable was created to evaluate the 
number of students who had ever used any one or more of the nine substances listed 
above. This new variable for any drug use, as well as the variables for each individual 
drug measured lifetime use with yes indicating that that student had used one or 
more substances one or more times in their life and no indicating that that student 
had never used one of the nine substances in their lifetime. Two different variables 
were also utilized to represent cigarette and alcohol use. Cigarette use was based on 
lifetime use or not of cigarettes. Alcohol use was demonstrated through the variable 
measuring the student reporting having one or more drink on one or more days within 
the last 30 days. Alcohol use was measured over the past 30 days instead of lifetime 
because of the high prevalence of one time use over the lifetime and to exclude 
those students who may have tasted alcohol in a religious or family tradition and not 
use independently. 
 The predictor variable investigated was student report of depressive 
symptoms, defined by the YRBS question: During the past 12 months, did you ever 
feel so sad or hopeless almost every day for two weeks or more in a row that you 
stopped doing your usual activities? This variable is dichotomous; yes indicating that 
that student felt sad for two weeks or more and no indicating that that student did not. 
The YRBS collects data on ethnicity as well. The myriad of combinations and 
responses for ethnicities were dichotomized for the purpose of this study into White 
and Non-White ethnicities. The original categories included in the Non-White 
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category were American Indian, Alaskan Native, Asian, Black, Native Hawaiian, 
Pacific Islander, Hispanic/Latino and any combination to include those students who 
identify with multiple ethnicities. Age, 14 to 18 years, and gender were also analyzed.  
 The data were analyzed using the IBM SPSS Statistics software. Frequencies 
and prevalence were run on the different variables. Odds ratios were calculated 
between use of any drug and depressive symptoms, gender and ethnicity. Odds 
ratios were also calculated between depressive symptoms and gender and 
depressive symptoms and ethnicity. Logistic regression analysis examined the 
relationship between any drug use and depressive symptoms controlling for gender, 
age, ethnicity, smoking status and alcohol use.   
Results 
 
Table 1: Demographics of the high school students who participated in the 2013 
Youth Risk Behavior Survey; N= 13,583. 
 
Sex 
Male 
Female 
 
(6,950) 51.2% 
(6,621) 48.7% 
Age 
14 years or younger 
15 years old 
16 years old 
17 years old 
18 years old or older 
 
(1,412) 10.5% 
(3,098) 22.8% 
(3,203) 23.7% 
(3,473) 25.6% 
(2,320) 17.1% 
Race/Ethnicity 
Non-Hispanic White 
Non-whitea 
 
(5,449) 41.1% 
(7,816) 56.7% 
Students Who Report  
Depressive Symptoms 
All 
Males 
Females 
White 
Non-white 
 
 
(4,086) 29.9% 
(1,492) 21.6% 
(2,592) 39.3% 
(1,527) 28.2% 
(2,466) 31.8% 
Students Who Report  
Use of Any Drug 
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All 
Males  
Females 
White 
Non-White 
(6,584) 51.5% 
(3,431) 52.9% 
(3,146) 50.1% 
(2,435) 46.9% 
(4,013) 54.8% 
a- Other race/ethnicities include: American Indian, Alaskan Native, Asian, Black, 
Native Hawaiian, Pacific Islander, Hispanic/Latino and multiple ethnicities. 
 
Table 2: Prevalence of substance use among all students, substance use among 
students who report depressive symptoms and substance use among students with 
no depressive symptoms. 
Substance All Students Depressive 
symptoms 
No depressive 
symptoms 
Marijuana 
 
Cocaine 
 
Inhalants 
 
Heroin 
 
Methamphetamines 
 
Ecstasy 
 
Steroids 
 
Prescription Meds 
 
Hallucinogens 
 
40.7% 
(5,782/13,244) 
5.5% 
(749/13,457) 
8.9% 
(1,178/13,369) 
2.2% 
(303/13,255) 
3.2% 
(415/13,357) 
6.6% 
(939/13,354) 
3.2% 
(419/13,454) 
17.8% 
(2,351/13,443) 
7.2% 
(898/12,520) 
54.3% 
(2,162/3,979) 
9.2% 
(372/4,050) 
15.6% 
(628/4,028) 
3.8% 
(150/3,991) 
5.6% 
(224/4,017) 
11.0% 
(443/4,017) 
5.0% 
(203/4,052) 
27.0% 
(1,093/4,050) 
11.1% 
(422/3,793) 
39.0% 
(3,580/9,187) 
3.9% 
(367/9,329) 
5.8% 
(539/9,268) 
1.6% 
(147/9,192) 
2.0% 
(187/9,266) 
5.2% 
(485/9,261) 
2.2% 
(208/9,326) 
13.3% 
(1,243/9,318) 
5.4% 
(467/8,657) 
1+ Substances 51.5% 
(6,584/12,775) 
65.7% 
(2,554/3,886) 
45.2% 
(3,984/8,815) 
Ever cigarette use 40.6% 
(5,360/13,203) 
52.0% 
(2,070/3,981) 
35.6% 
(3,256/9,152) 
1+ days had drink in last 
30 days 
35.6% 
(4,373/12,228) 
46.7% 
(1,1705/3,649) 
30.9% 
(2,645/8,570) 
 
 
Table 3: Odds Ratios between drug use, depressive symptoms, gender and ethnicity. 
 Χ2 P value Odds Ratio (95% CI) 
Use of any drugs 
Depressive Symptoms  
Male Gender 
Other Ethnicity 
 
 
454.982 
10.211 
76.406 
 
<.001 
<.001 
<.001 
 
1.454 (1.408-1.502) 
1.060 (1.023-1.099) 
1.176 (1.134-1.219) 
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Depressive Symptoms 
Female Gender 
Other Ethnicity 
 
500.404 
19.817 
 
<.001 
<.001 
 
1.493 (1.444-1.543) 
1.072 (1.040-1.105) 
 
 In the sample of high school students, 51.5% admitted to using one of the nine 
substances in their lifetime. Further breakdown of the prevalence of use of each 
individual substance can be found in Table 2. Marijuana was the substance with the 
highest prevalence with 40.7% of the students reporting use. The substance with the 
second highest prevalence was taking a prescription medication without a doctor’s 
prescription at 17.8%. The least often reported substance was heroin with 2.2% of 
the population using this substance. The two other substance variables analyzed 
were lifetime use of cigarettes (40.6%) and having a drink on one or more days within 
the last 30 days (35.6%). Depressive symptoms were reported by 29.9% of the 
students. Of those that reported depression symptoms, 65.7% reported using one or 
more of the nine substances. The students who did not report depressive symptoms 
reported use of one or more drugs as 45.2%. 
 Each of the examined OR were statistically significant (all p <.001). Students 
reporting depressive symptoms had a significantly higher rate of drug use (OR=1.454 
(1.408-1.502, χ =454.98, p <.001). Males reported more drug use than females 
(1.060 (1.023-1.099); p <.001). Non-white ethnicities had a higher odds ratio than 
white students for using any drugs (1.176 (1.134-1.219); p <.001). Females had a 
higher odds ratio than men for reporting depressive symptoms (OR= 1.493 (1.444-
1.543); p <.001) as well as ethnicities other than white (OR= 1.072 (1.040-1.105); p 
<.001).  
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 Binary logistic regression assessed the relationship between age, gender, 
ethnicity, smoking history, recent drinking history and depressive symptoms and any 
history of drug use. There was a significant difference between students who used 
any one versus none of the nine drugs, b=0.020, SE=0.019, Wald=1.15, p=.28. 
There is a significant effect of gender on drug use, χ2= 9.89, p=.002, b=0.119, 
S.E.=0.038, Wald=9.89, p=.002, such that male students reported higher rates of 
drug use than female students. Students of races and/or ethnicities other than non-
Hispanic white reported using drugs at a significantly higher rate than their white 
counterparts, χ2= 48.725, p <.001, b=0.268, S.E.=0.038, Wald=48.60, p <.001. Age 
had a significant effect on drug use, with older students reporting more drug use 
history than younger students, χ2= 255.787, p= <.001, b=0.246, S.E.=0.016, 
Wald=249.740, p= <.001. Lifetime smoking status and alcohol consumption in the 
last 30 days were both significant in the model for predicting students drug use with 
tests statistics χ2= 4232.52, p <.001, b=-2.100, S.E.=0.051, Wald=1686.988, p= 
<.001 and χ2= 4232.52, p <.001, b= -1.671, S.E.=0.052, Wald=1024.877, p <.001 
respectively. Those who reported ever having smoked a cigarette or drinking on one 
or more days in the last 30 days, were more likely to use one or more of the nine 
substances. When lifetime smoking status and recent history of drinking were 
entered into the model, gender was no longer significant, b=0.075, SE = 0.048, 
Wald=2.506, p=.113.  
 The final model was calculated to predict drug use and included depressive 
symptoms after controlling for age, gender, ethnicity, smoking status and recent 
drinking history. Those reporting the presence of depressive symptoms were more 
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likely to report drug use, χ2= 132.12, p <.001, b=-0.619, S.E.=0.054, Wald=131.569, 
p <.001. Each of the predictors remained statistically significant (p <.001) in the final 
model.  
Discussion 
 The findings of this study demonstrate that a history of depressive symptoms 
is associated with a history of illicit drug use regardless of gender and ethnicity in a 
nationally representative sample of high school students in the United States. In this 
study, students who reported depressive symptoms were more likely to have tried 
marijuana, cocaine, inhalants, heroin, methamphetamines, ecstasy, steroids, 
prescription medications or hallucinogens regardless of ethnicity or gender. This is 
indicative of a strong association between drug use and depressive symptoms. 
Though this study does not address the subject of causality or temporality between 
substance use and depression present in these students, it does demonstrate that 
depressive symptoms and substance use are linked. This is consistent with previous 
research that has focused on clinically diagnosed adolescents with either condition 
(Rao et al., 2000; Libby et al., 2005; Rohde et al., 2001; Marmorstein et al., 2010). 
This shows that though these students may or may not have a specific clinical 
diagnosis of a mental disorder, history of substance use and the presence of 
depressive symptoms are strongly associated with one another.  
 Adolescence is a time of change, self-discovery and challenges. Adolescents 
face numerous challenges and changes in their bodies, minds and social spheres as 
they navigate through this time period, which makes this a high risk time period (Rao, 
2006). Adolescence is a time of transition into early adulthood as young minds 
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develop, personal adjustments are made, and social pressures abound (Marmorstein 
et al., 2009). Often, in the struggle to find themselves, adolescents engage and 
experiment in risky behaviors (Taylor, 2011). Since adolescence is such a crucial 
transition period in life, with many new experiences and emotions and often in 
extremes, this is also the time frame in which many mental disorders first develop 
(Marmorstein et al., 2009; Taylor, 2011). Though everyone at some point in their lives 
feels stressed, depressed, anxious or sad, when these emotions occur for extended 
lengths of time, normal daily functioning can be affected. For many years it was 
thought that depression could not occur in adolescence (Taylor, 2011). Often 
emerging mental disorder symptoms, such as changing abnormal moods and 
behaviors, are seen as normal teenage angst or rebellion against school, parents 
and peers (Weller & Weller, 2000). Research has established evidence that mental 
disorders such as major depression and substance abuse are prevalent in the 
adolescent population. Often it is in adolescence that these ‘adult’ diagnoses first 
appear. The incidence of depression and substance abuse in adolescents is 5-10% 
(Rao, 2006). This increase in prevalence of adolescent mental disorders may be due 
to the awareness that these diagnoses do exist in this population. Growing research 
in this area has found prevalence rates of clinically diagnosed depression among 
adolescents anywhere from 6.3% to 10.3% (Baumeister & Harter, 2007; Taylor, 
2011; Libby et al., 2005; Deykin et al., 1987). The prevalence rate of substance 
abuse is approximately 2-28%, with 28% being much higher than the average of 
around 2-9% (Sung et al., 2004; Libby et al., 2005; Deykin et al., 1987), with the rate 
of use being much higher. In this study, which did not look at a clinical diagnosis of 
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substance abuse, but rather the history of any substance use, the prevalence rate 
was much higher. The prevalence rate for any substance use history among this 
population was 51.5%.  
 Among adolescents, co-morbidity is more a rule than the exception. While 
adults have co-morbid rates of approximately 40%, adolescents can have co-morbid 
rates of mental disorders as high as 90% (Weller & Weller, 2000; Rohde et al., 2001). 
As with adults, the most common co-morbid mental disorders are mood disorders, 
anxiety disorders and substance abuse, although this co-occurrence appears to be 
stronger in adolescents than in adults (Marmorstein et al., 2009).  A particular pattern 
has been emerging from adolescent studies in community settings: co-morbid rates 
of depression and substance use and abuse are among the most common co-
occurring disorders (Martins et al., 2012; Taylor, 2011; Aseltine et al., 1998). 
Adolescents have the highest risk for the onset of both depression and substance 
use disorders and the co-morbidity of these disorders is even higher among 
adolescents than adults (Rao et al., 2000). Fifteen to 24 year olds have the highest 
rate of prevalence of 12-month mental disorders, and the highest level of co-
morbidity as well (Aseltine et al., 1998). Examining this rate of co-occurrence in 
adolescents is important as early onset doubles the risk for developing or persisting 
mental disorders later in life into adulthood (Aseltine et al., 1998). This is significant in 
adolescents because the presence of a disorder in adolescence is highly correlated 
with the presence of a disorder in adulthood. Substance abuse demonstrates 
significant stability over time with 66% of adolescents with substance abuse 
continuing to have this diagnosis into early adulthood (Aseltine et al., 1998). 
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Depression in adolescents continues into adulthood at a rate of 60-70% (Weller & 
Weller, 2000). Adolescents with one diagnosis were more than twice as likely to 
develop a second mental health diagnosis as adults (Aseltine et al., 1998). In this 
study, the prevalence of students who reported depressive symptoms as well as any 
substance use history was 65.7%, which is consistent with previously established 
prevalence rates (Aseltine et al., 1998; Weller & Weller, 2000). 
  One explanation for the more frequent occurrence of co-morbidities in 
adolescence is their developing brain. Rao (2006) found that animal studies indicate 
that adolescent substance use can have a stronger effect on the brain than adult 
brains, leading to more severe dependence. Substances are highly rewarding but 
withdrawing from substances can also trigger depressive symptoms or mood, and 
when depression is co-morbid, function is further compromised (Rao, 2006). There 
are also much stronger social pressures during adolescence. Social interactions are 
influential throughout the lifespan, but at this important time of development and new 
perceived independence, social pressures are especially influential. One study, 
Aseltine et al. (1998), found that positive relations with peers was associated with 
lower levels of depression and peer pressure is strongly associated with substance 
abuse.  
 Depression has been found to occur early in childhood, frequently between 
the ages of 13 and 15 years old, with some studies suggesting that depression may 
actually be symptomatic even earlier in childhood (Sung et al., 2004). Substance use 
was found to increase if initiation of use occurred before age 13 (Sung et al., 2004). 
For those adolescents who were introduced to drug use at such early ages, the 
 15 
amount of drug use increased, placing these adolescents at a higher risk of 
dependence and other negative effects of substance use. Early use of substances 
also increased the likelihood of using substances later in adolescence and early 
adulthood (Chinet et al., 2006). This was also found to be true when comparing 
adolescents to young adults. Those who initiated substance use in their adolescence 
are more likely to engage in substance use in their adulthood and develop more 
serious substance abuse and dependence.  
 Mental health disorders are important to recognize early and provide treatment 
opportunities because of the negative impact they can have throughout the lifespan. 
Mental health disorders can begin in adolescence and become life long battles if 
undiagnosed, untreated, mistreated or undertreated. Early onset of mental disorders 
in adolescents is associated with developing Kinner et al. (2001) found the 
relationship between drug use and psychological health to be linear; the more drugs 
consumed, the poorer the psychological health. Though adolescents can be 
adaptive, difficulties at any point in this stage of life may effect further adaption and 
quality of life into adulthood (Aseltine et al., 1998). Substance use disorder and 
depression are associated with significant psychosocial dysfunction, and when these 
two disorders are co-morbid, the dysfunction is even more severe (Rao et al., 2000). 
 There are many other negative associations with substance use and 
depression that have been explored in adult populations and adolescent populations. 
Negative risks from depression and substance use in adolescence are especially 
significant because they can deter later success in adulthood. Substance use and 
depression are associated with behavioral problems, low academic competencies, 
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poor interpersonal relationships, increased utilization of services and an elevated risk 
of suicide (Rao et al., 2000). Substance use disorders in adolescence are associated 
with hospitalization, depression, suicide, HIV, and poor family function (Drake et al., 
1998). Alcohol and drug use negatively affects family functioning, academic 
performance and lessens the possibility of college (Aseltine et al., 1998). Other 
consequences from substance use and depression include: high levels of stress, 
poor coping, low academic achievement, low parental support, poor behavioral 
control, and parental or peer substance use (Chassin et al., 2002). These negative 
outcomes of substance use and depression could also be potential risk factors for 
both substance use and depression creating an almost cyclic effect of exposures.  
 Suicide is a severe and devastating occurrence that is associated with drug 
use and depression. Suicide is now the third leading cause of death among 
adolescents (Wong et al., 2013). Suicide has become a leading cause of death 
among adolescents and an important public health concern. Among adolescents, 
suicide is especially disheartening since those who were suffering had not yet even 
reached adulthood. The suicide rate for adolescents has quadrupled over the last 40 
years; in 1950 the rate was 2.7 per 100,000 and in 1990 was 11.1/100,000 (Weller & 
Weller, 2000). Wong et al. (2013) found that use of drugs significantly increased the 
odds of adolescents reporting suicidal ideations, suicidal plans, suicide attempts and 
suicide attempts resulting in severe injury. Among students who used heroin, suicide 
attempts occurred at rate three times as much as those students who did not use 
heroin (Wong et al., 2013). Among students who did not report using any type of 
substance, the suicide rate among high school students was 2.2%, and increasing th 
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number of substances used, the rate of suicide attempt also increased with students 
who used five or more substances having a suicide attempt rate of 18% (Wong et al., 
2013). The other significant risk factor for suicide among adolescents is depression. 
Of high school students who report depressive symptoms, 21.6% attempted suicide 
(Wong et al., 2013).  
 Research has shown that females are more likely to experience depression 
than males (Weller & Weller, 2000; McHugh et al., 2013; Taylor, 2011; Chinet et al., 
2006; Aseltine et al., 1998). Males tend to use substances generally more than 
females (McHugh et al., 2013). Females may generally report more depression and 
males may generally report more substance abuse, but when the two problems co-
occur the gender difference disappears (Aseltine et al., 1998). If there is a substance 
use disorder present before the age of 17, both males and females are at an 
increased risk of having a substance use disorder at age 24 (Marmorstein et al., 
2009). Females with substance abuse disorder report greater functional impairment, 
greater psychiatric severity and a higher likelihood of reporting use of substances to 
cope with emotional distress (McHugh et al., 2013). Substance use and depression 
are more strongly associated within females than males (Marmorstein et al., 2009). 
Females reported greater impairment then males did in employment and social and 
family functioning (McHugh et al., 2013). For females, if depression occurs before the 
age of 17 years old, they are four times more likely to continue to have depression 
into their adulthood (Marmorstein et al., 2009). The risk for depression in women with 
substance use disorders is high, with 71.4% of the females with substance abuse 
during follow up also having a comorbid diagnosis of depression (Aseltine et al., 
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1998). There are some differences in the substances that each gender chooses to 
engage in, for example, prescription medication misuse is more common among 
white, young females (Bohnert et al., 2013) while males tend to drink more often and 
heavier than females (Chassin et al., 2002).  
 In this study, female students were found to have a high risk of reporting 
depressive feelings. Evidence suggests that this pattern continues into adulthood 
where women are more prone to be depressed than men. However, there was no 
difference in the likelihood of using illicit drugs between males and females in this 
study; 50.1% of the high school female population reported using at least one of the 
nine substances compared to 52.9% of males. With high rates of drug use history 
and higher rates of depressive symptoms, females may be at more risk than males 
for future negative outcomes. As studies have shown, females with depressive 
symptoms in their adolescence are more likely to be depressed as adults and also 
have substance use disorders (Aseltine et al., 1998; Marmorstein et al., 2009). 
 There are a wide variety of substances both legal and illegal available to 
adolescents. The availability and prevalence of some substances may differ among 
geographical regions, but essentially almost all substances are available across the 
nation in rural and urban communities. Alcohol and marijuana are the most widely 
used substance among adolescents. Among adolescents, 6.5% state that they use 
marijuana daily (Chinet et al., 2006). Prescription medication misuse has become an 
increasingly concerning trend. The Drug Abuse Warning Network has reported 
medical emergencies involving the misuse of prescription medications has increased 
81% (Zullig & Divin, 2012). Studies have shown that adults are increasingly misusing 
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their prescription medications and this trend has appeared in the adolescent 
population as well (Bohnert et al., 2013). There is a high correlation between 
prescription drug misuse and heroin use (Bohnert et al., 2013). Prescription 
medications are highly reinforcing, similar to heroin, and prolonged use can produce 
neurological changes and dependence (Martins et al., 2012). In 2005, 8.2% of 
adolescents misused prescription medications and the risk for misusing prescription 
medication was three times higher when the adolescent also had a diagnosis of 
major depression (Schepis & Krishnan-Sarin, 2008). Only past month use of alcohol, 
tobacco and marijuana exceeds the rate of prescription medication misuse (Schepis 
& Krishnan-Sarin, 2008). Accumulating findings are showing that though males tend 
to be at a greater risk of substance use, females are at a greater risk for prescription 
medication misuse (Schepis & Krishnan-Sarin, 2008).  
 Marijuana, cigarettes, and alcohol are the most used substances among 
students, both with and without depressive symptoms, but even among these three 
popular substances, those with depressive symptoms had a higher prevalence of use 
than those without depressive symptoms. Overall, 40.7% of students reported lifetime 
marijuana use, and 54.3% of students who reported depressive symptoms also 
reported ever using marijuana. For every substance, use was higher among students 
with depressive symptoms. Females may be more prone to use prescription 
medication because it is technically legal, deemed safe, prescribed by a doctor and 
often easily swallowed (Schepis & Krishnan-Sarin, 2008). Regardless of substance of 
choice, the presence of depressive symptoms increased the likelihood of a drug use 
history. 
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 Risk factors for developing depression or using substances have been 
explored in many studies, but many remain uncertain and there is a lot of variation. 
Aseltine et al. (1998) in a review of the literature found that many risk factors are 
associated with increased substance use and depression such as a stressful family 
life, poor family relationships and negative social relationships. Though family 
situations are important in contributing to an adolescent’s mental health and social 
adaptation, in this malleable stage of development, peers are often more strongly 
linked with drinking and drug use. An adolescent’s failure in self-regulation is also an 
important contributing risk factor for substance use. Schepis & Krishnan-Sarin (2008) 
found African American or Hispanic was protective for prescription drug abuse but in 
the present study, non-white students were found to be at higher risk for both 
depressive feelings and substance use. This finding suggests non-white adolescents 
may be at a higher risk for potential negative outcomes from both substance use and 
depression.  
 Among adolescents, some risk factors are unique to this stage in life, including 
boredom, peer pressure, curiosity, drug availability, and frustration (Taylor, 2011). 
Low socioeconomic status and poverty have also been linked to depression and 
substance abuse (Taylor, 2011). Adolescence is also a time for experimenting. 
Adolescents experiment with style, interests, hobbies, friends, and behaviors. It is not 
clear if experimentation with different substances increases the risk of developing 
substance abuse or depressive symptoms, but some studies have shown that 
adolescents who are depressed progress much quicker to clinical substance use 
disorders when they engage in experimentation with substances than adolescents 
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who are not depressed (Rao et al., 2000). Though this study does not distinguish 
between experimenters and regular users, it does capture both of students who have 
used only a few times as well as those who use substances regularly.  
 Though independent risk factors may influence the development of either a 
substance use disorder or depression, one disorder may influence the development 
of the other as well. There are several different theories regarding the association 
between substance abuse and depression. These include that substance use 
triggers depressive symptoms, those with depressive symptoms use substances in 
order to self medicate, and a shared influence in which there is a third factor which 
increases the likelihood of each disorder occurring (Martins et al., 2012). It is difficult 
to determine the temporality of either disorder. Evidence has been recorded for all 
three variations of the timing of depression and substance use (Martinss et al., 2012). 
In one study, they found that 70% of adolescents with a substance use disorder had 
depressive symptoms prior to their substance use disorder, while 30% experienced 
depressive symptoms at the same time or after their substance use disorder 
developed (Libby et al., 2005). When substance use was reported first, 71% of these 
were boys and 37% white (Libby et al., 2005). One study found that low self-esteem 
induced drug use, which in turn actually increased self-esteem, leading the 
investigators to infer that depression lead to first substance use (Deykin et al., 1987). 
Though it is potentially helpful to learn which mental disorder first arises, the 
temporality of these disorders eventually becomes less important since both 
disorders are linked (Deykin et al., 1987). The fact that both of these disorders occur 
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in adolescence is more important to address because of the detrimental effect these 
disorders have on chronic disability and functioning (Deykin et al., 1987).  
 The risk factors often associated with depression and substance use can be 
interchangeable. Poor family situations, stress at home, low socioeconomic status, 
negative peer pressure and parental substance use or depression are all risk factors 
for both depression and substance use. It is important to note that though these are 
separate diagnoses, in adolescence, where co-morbidity is more common than in 
adult populations, treating them as separate diagnoses may not be as effective in this 
population. Many of these students may also be presenting with sub-threshold 
symptoms of either substance use or depression, so special attention should be 
given to these students and this situation. This study shows that use of even one 
drug of the nine different substances examined, is associated with depressive 
symptoms regardless of gender or ethnicity. Adolescents with substance use 
disorders may fail to develop adaptive methods of coping with negative feelings or 
stressful situations and this may lead to depressive feelings (Marmorstein et al., 
2009). Experimentation of even one substance a few times and the association with 
depressive symptoms could be indicative of a potential future diagnosis, or one of the 
many negative outcomes that may occur from development of a mental disorder.  
 The importance of these relationships and the high prevalence of use and 
depressive symptoms in students emphasize the need for understanding the 
motivations behind drug use and to help develop specific treatments and 
interventions (Rigg et al., 2010). Since it is difficult to determine causality and the 
high rate of co-morbidity, these two diagnoses should not be considered as linked 
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processes that most likely influence each other. The risk factors should be examined 
for both substance abuse and depression to find those that are most linked to both 
disorders. This could create a comprehensive platform in which interventions could 
be assembled to address both problems. Treatment is difficult and often unsuccessful 
for people with co-morbid mental disorders (Drake et al., 1998). A study found that 
only 31% of those with co-morbid diagnoses completed intensive integrated 
programs (Drake et al., 1998). It is essential to have early intervention programs and 
specific prevention programs. Research in adults has shown treatment of one 
disorder such as depression can positively effect the other co-morbid disorder 
(Rohde et al., 2001). Early intervention and awareness of these mental disorders, in 
all manifestations, can help in the prevention of substance use or depression 
effecting adolescence and address the symptoms before it becomes a problem.   
Limitations 
 There are several limitations to this study. The first is that this is a cross-
sectional study design, which examines a sample at a specific moment in time. This 
study design does not allow for inferences in the direction of causality between the 
two variables of depressive symptoms and substance use. This study can only look 
at the associations between the two variables at this specific time. A prospective 
study considering several years of data would be better able to assess direction and 
causality.  
 This study also did not measure specific diagnoses. Though this study design 
allowed for a larger sample size and was more inclusive to include those that may 
have symptoms but not necessarily a disorder, it also potentially includes those who 
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do not have a mental disorder and may never develop one. Student report of feeling 
sad was used to represent depressive symptoms, but does not differentiate those 
students who may also be diagnosed with depression. Substance use was based off 
of lifetime use of any drug with one time use of any drug being a positive answer. 
This strategy includes all students who have used a substance in their lifetime, but 
does not differentiate between frequent or current use of substances. This method 
could potentially include students who have tried a substance once, but currently do 
not use substances and may never use again.  
 In this study, no other baseline information was taken from students to 
determine if there are other associations with being in either ethnicity sub category. 
The non-white ethnicity group includes minority populations that are often associated 
with living in urban, underserved areas and lower socioeconomic status. This may be 
a significant contributing factor to the increased rate of substance use and 
depressive feelings among non-white students. This is an important and intriguing 
topic for future research.  
 The most important limitation of this study was the lack of assessment of other 
potentially influential confounders. The YRBS does not assess many aspects of the 
students’ life inside the home or their family situations. The study is limited by the 
lack of access to information about the students’ socioeconomic status, location, 
family structure, parental relationships and adverse childhood exposures. There are 
many other aspects of the adolescents’ lives that could potentially influence the use 
of substances or the development of depressive symptoms. Family situations are 
highly influential in an adolescent’s life and this domain of adolescent life warrants 
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further investigation. Other adverse childhood events such as abuse, neglect, 
parental substance use, parental depression, foster care, injury, illness and others 
could potentially influence the development of either depression or substance use. 
This study also did not address other mental disorders that occur during this time in 
adolescence, such as anxiety and conduct disorders.  
Conclusions and Recommendations 
 Adolescence can be a difficult and exciting time for many. It is also a time 
where emerging mental health and substance use disorder symptoms of mental 
disorders that can have lifelong effects first occur. The potential negative effects and 
persistence into adulthood of these symptoms of mental disorders makes recognizing 
and addressing these emerging mental disorders in adolescence a priority. 
Substance use and depression are associated with increased disability, morbidity 
and mortality if they persist into adulthood. This study established that there is an 
association between substance use and depressive symptoms among high school 
students. The presence of any drug use history and feeling sad were associated. 
These broad categories across a large, national sample of high school students 
demonstrate the pervasive problem that exists. Substance use and depressive 
symptoms are not isolated to a specific subgroup of the population and many 
different substances are utilized.   
 Further research examining the changes in these populations over time may 
yield further insight into this relationship across specific subgroups of adolescents. 
Continued research of potential at risk populations may further help design and 
establish targeted interventions. Understanding the relationship and possible risk 
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factors between depression and drug use in adolescence ultimately needs to lead to 
potential interventions that will be targeted to treat these individuals early and prevent 
adolescent symptoms from becoming lifelong battles.  
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Appendix 
 
Youth Risk Behavior Surveillance Survey Questions 
 
Q1: How old are you? 
A. 12 years old or younger 
B. 13 years old 
C. 14 years old 
D. 15 years old 
E. 16 years old 
F. 17 years old 
G. 18 years old or older 
 
Q2: What is your sex? 
A. Female 
B. Male 
 
Q5: What is your race? (Select one or more responses.) 
A. American Indian 
B. Asian 
C. Black or African American 
D. Native Hawaiian or Other Pacific Islander 
E. White 
 
Q26: During the past 12 months, did you ever feel so sad or hopeless almost every 
day for two weeks or more in a row that you stopped doing some usual activities? 
A. Yes 
B. No 
 
Q31: Have you ever tried cigarette smoking, even one or two puffs? 
A. Yes 
B. No 
 
Q43: During the past 30 days, on how many days did you have at least one drink of 
alcohol? 
A. 0 days 
B. 1 or 2 days 
C. 3 to 5 days 
D. 6 to 9 days 
E. 10 to 19 days 
F. 20 to 29 days 
G. All 30 days 
 
Q47: During your life, how many times have you used marijuana? 
A. 0 times 
B. 1 or 2 times 
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C. 3 to 9 times 
D. 10 to 19 times 
E. 20 to 39 times 
F. 40 to 99 times 
G. 100 or more times 
 
Q50: During your life, how many times have you used any form of cocaine, including 
powder, crack, or freebase? 
A. 0 times 
B. 1 or 2 times 
C. 3 to 9 times 
D. 10 to 19 times 
E. 20 to 39 times 
F. 40 or more times 
 
Q51: During your life, how many times have you sniffed glue, breathed the contents 
of aerosol spray cans, or inhaled any paints or sprays to get high? 
A. 0 times 
B. 1 or 2 times 
C. 3 to 9 times 
D. 10 to 19 times 
E. 20 to 39 times 
F. 40 or more times 
 
Q52: During your life, how many times have you used heroin (also called smack, 
junk, or China White)? 
A. 0 times 
B. 1 or 2 times 
C. 3 to 9 times 
D. 10 to 19 times 
E. 20 to 39 times 
F. 40 or more times 
 
Q53: During your life, how many times have you used methamphetamines (also 
called speed, crystal, crank, or ice)? 
A. 0 times 
B. 1 or 2 times 
C. 3 to 9 times 
D. 10 to 19 times 
E. 20 to 39 times 
F. 40 or more times 
Q54: During your life, how many times have you used ecstasy (also called MDMA)? 
A. 0 times 
B. 1 or 2 times 
C. 3 to 9 times 
D. 10 to 19 times 
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E. 20 to 39 times 
F. 40 or more times 
 
Q55: During your life, how many times have you taken steroid pills or shots without a 
doctor’s prescription? 
A. 0 times 
B. 1 or 2 times 
C. 3 to 9 times 
D. 10 to 19 times 
E. 20 to 39 times 
F. 40 or more times 
 
Q56: During your life, how many times have you taken a prescription drug (such as 
OxyContin, Percocet, Vicodin, codeine, Adderall, Ritalin, or Xanax) without a doctor’s 
prescription? 
A. 0 times 
B. 1 or 2 times 
C. 3 to 9 times 
D. 10 to 19 times 
E. 20 to 39 times 
F. 40 or more times 
 
Q87: During your life, how many times have you used hallucinogenic drugs, such as 
LSD, acid, PCP, angel dust, mescaline, or mushrooms? 
A. 0 times 
B. 1 or 2 times 
C. 3 to 9 times 
D. 10 to 19 times 
E. 20 to 39 times 
F. 40 or more times 
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